The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor
Ovation Fertility
Study ID
NCT06521372
Status
Recruiting

Conditions

  • Infertility Primary

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • Magenta AI image analysis tool — OTHER
    MagentaTM is a non-invasive image analysis tool that utilizes artificial intelligence to evaluate 2-dimensional images of denuded mature MII oocytes. The MagentaTM software has been analyzed retrospectively, by Future Fertility. This data displays that a higher MagentaTM score is associated with a higher chance of blastocyst development. Additionally, the MagentaTM software has been validated in a prospective multi-center study, displaying that a higher MagentaTM score correlates to a higher chance of blastocyst development.

Study Details

The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.

Key Dates

Start date
Jan 1, 2024
Status verified
Jul 2024
Primary completion
Jan 1, 2026
Completion
Jan 2, 2027

Study Design

Enrollment
450 participants (estimated)

Arms

  • Arm: Oocytes with AI
    Oocytes assessed by the Magenta software
  • Arm: Oocytes without AI
    Oocytes randomly selected

Primary Outcome Measure

Compare blastocyst development rate [ Time Frame: 5 to 7 days ]

Locations (3)

FacilityCityStateZIPSite coordinators
Ovation Fertility Las VegasLas VegasNevada89113
Matthew VerMilyea, PhD
512-980-0310
Matthew VerMilyea, PhD (PRINCIPAL_INVESTIGATOR)
Ovation Fertility CincinnatiCincinnatiOhio45209
Matthew VerMilyea, PhD
512-980-0310
Matthew VerMilyea, PhD (PRINCIPAL_INVESTIGATOR)
Ovation Fertility - NashvilleNashvilleTennessee37203
Matthew VerMilyea, PhD
512-980-0310
Matthew VerMilyea, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Las Vegas, NV